Stock News Alert: ThermoGenesis Holdings (NASDAQ:THMO)

January 6, 2020

ThermoGenesis Holdings (NASDAQ:THMO) stock observed trading -38.43% off 52-week high price. On the other end, the stock has been noted 83.40% away from low price over the last 52-weeks. The stock disclosed a move of 13.80% away from 50 day moving average and 21.18% away from 200 day moving average. Moving closer, we can see that shares have been trading 39.08% off 20-day moving average. It has market cap of $11.72M.

On Jan. 03, 2020, ThermoGenesis Holdings (NASDAQ:THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, declared that ImmuneCyte Life Sciences (ImmuneCyte), an 80/20 joint venture between HealthBanks Biotech (USA) and ThermoGenesis, has closed a $3.0 million equity investment with a private institution. The investor received 600,000 shares of Class A common stock at $5.00 per share, representing a 5.66% ownership in the joint venture. As a result of this equity investment in ImmuneCyte, ThermoGenesis’ equity in the joint venture is no longer subject to the anti-dilution provision. After this investment, ImmuneCyte is owned 75.47% by HealthBanks Biotech (USA), 18.87% by ThermoGenesis Holdings and 5.66% by the private institution.

ImmuneCyte is a joint venture which was created in order to provide immune cell banking services to healthy customers, enabling them to store their healthy immune cells for potential future use in immunotherapies, leveraging ThermoGenesis’ proprietary CAR-TXpress™ platform and HealthBanks’ global, stem cell banking network. ImmuneCyte isolates healthy immune cells from 150-200ml of peripheral blood with a proprietary, automated cell processing platform developed by ThermoGenesis, which makes ImmuneCyte the first cell bank capable of processing immune cells under a functionally-closed and fully cGMP compliant environment, a quality control element which is essential for cell and gene therapies.

The stock was observed in the 5 days activity at 60.82%. The one month performance of stock was 33.44%. THMO’s shares are at -31.37% for the quarter and driving a 58.46% return over the course of the past year and is now at -2.05% since this point in 2018. Right now the stock beta is 0.91. The average volatility for the week and month was at 26.26% and 10.45% respectively. There are 2.72M shares outstanding and 2.16M shares are floated in market.

Leave a Reply

Your email address will not be published. Required fields are marked *